POTTS JOHN T JR 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Oct 15, 2009
Insider Transaction Report
Form 4
POTTS JOHN T JR
Director
Transactions
- Award
Common Stock
2009-10-14+5,581→ 5,581 total - Award
Stock Option (right to buy)
2009-10-14+15,000→ 15,000 totalExercise: $1.82Exp: 2019-10-13→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Received in exchange for 30,536 shares of Cell Genesys, Inc. ("Cell Genesys") common stock in connection with the merger of Cell Genesys with and into BioSante (the "Merger"). Each share of the reporting person's Cell Genesys shares was exchanged for 0.1828 of a share of BioSante common stock in conenction with the Merger.
- [F2]Option granted on October 14, 2009. Vesting occurs in four equal yearly installments, with the first installment becoming exercisable on the one-year anniversary of the grant date.